Home Trending Stocks Palatin Technologies Inc. (NASDAQ: PTN) stock surges during after-market trading. Let’s find...

Palatin Technologies Inc. (NASDAQ: PTN) stock surges during after-market trading. Let’s find out why?

Palatin Technologies Inc. (NASDAQ: PTN) stock gained by 23.49% at the last close while the PTN stock price rises by 0.18% in the after-market trading session. Palatin is a biopharmaceutical firm focused on creating first-in-class medications that target the melanocortin and natriuretic peptide receptor systems. The targeted, receptor-specific pharmaceutical candidates developed by PTN are used to treat illnesses with a high unmet medical need and economic potential.

>> 7 Top Picks for the Post-Pandemic Economy << 

What is happening?

Palatin Technologies has completed an End-of-Phase 2 (EOP2) meeting with the US Food and Drug Administration (FDA) for PL9643, a dry eye condition therapy (DED).


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Sponsored


The FDA and Palatin reached a deal on the essential elements of a pivotal Phase 3 clinical program, covering study design, endpoints, interim evaluation, and patient population, at the EOP2 conference, which covered all parts of PL9643’s development plan. A possible second Phase 3 trial, as well as a long-term safety study, were also considered in order to support a New Drug Application (NDA). Palatin expects to start the Phase 3 program in DED patients in the fourth quarter of 2021, with data readout in the second half of 2022. If all goes according to plan, an NDA will be submitted in the second half of the calendar year 2023.

Read More

Official Statements

Michael Raizman, Chief Medical Officer of Palatin stated,

As a practicing ophthalmologist, he is encouraged by the preliminary findings on the PL9643 program, which provides much-needed hope for successful dry eye therapy without side effects. However, he is also looking forward to seeing further evidence of PL9643’s potential to revolutionize the topical treatment of DED for the millions of individuals who suffer from it.

Carl Spana, President and Chief Executive Officer of Palatin commented that,

After reaching an agreement with the FDA on all major components of PL9643’s pivotal phase 3 study for DED, they now have insight on the registrational path necessary to establish the safety and effectiveness of the drug. This is a significant business milestone since they now have a second melanocortin agonist in phase 3 development, which they feel confirms their approach of developing melanocortin-based therapies for inflammatory and autoimmune diseases.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Havertys Furniture Companies Inc. (HVT) stock gains during after-hour trading, Here’s to know why?

Havertys Furniture Companies Inc. (NASDAQ: HVT) stock declined by 0.39% at last close whereas the HVT stock price gains by 4.6% in the after-hours...

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Flora Growth Corp. (FLGC) stock declines during premarket. Here’s what you should know?

Flora Growth Corp. (NASDAQ: FLGC) stock gained by 49.67% at last close whereas the FLGC stock price plunged by 18.36% in the pre-market trading...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

Virios Therapeutics Inc. (VIRI) stock fell during current market. What’s behind this?

Virios Therapeutics Inc. (NASDAQ: VIRI) stock price plunged by 1.46% in the current market trading session. Virios Therapeutics is a medical biotechnology firm focusing...

Infinity Pharmaceuticals Inc. (INFI) stock gains during pre-market. Let’s see why?

Infinity Pharmaceuticals Inc. (INFI) stock declined by 31.53% at the last close whereas the INFI stock price surges by 49.34% in the pre-market trading...

Why Futu Holdings Limited (FUTU) stock is surging in pre-market on Wednesday?

Futu Holdings Limited (FUTU) shares surged 7.56% in pre-market on Wednesday, July 28, 2021, as of this writing. Yesterday in the after-hours session, FUTU's...

Related News

Havertys Furniture Companies Inc. (HVT) stock gains during after-hour trading, Here’s to know why?

Havertys Furniture Companies Inc. (NASDAQ: HVT) stock declined by 0.39% at last close whereas the HVT stock price gains by 4.6% in the after-hours...

Oragenics Inc. (OGEN) stock gained during current market. What’s driving it high?

Oragenics Inc. (OGEN) stock gains by 54.33% during the current market trading session. Oragenics, is a research and development firm focused on combating infectious...

Flora Growth Corp. (FLGC) stock declines during premarket. Here’s what you should know?

Flora Growth Corp. (NASDAQ: FLGC) stock gained by 49.67% at last close whereas the FLGC stock price plunged by 18.36% in the pre-market trading...

Palatin Technologies Inc. (PTN) stock rises during pre-market trading. What has been happening lately?

Palatin Technologies Inc. (NASDAQ: PTN) stock declined by 1.16% the last close whereas the PTN stock price gains by 3.91% in the pre-market trading...

Smith Micro Develops Inc. (SMSI) stock soars during current market trading. Here’s to know why?

Smith Micro Develops Inc. (NASDAQ: SMSI) stock surged by 2.39% during the current market trading session. Smith Micro creates software that simplifies and improves...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam